Epirubicin, an effective new anticancer agent.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D015251:Epirubicin; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy
D000970:Antineoplastic Agents; D015251:Epirubicin; D004317:Doxorubicin